CO-DIRECTOR

Dr. Jeffrey Milsom was the first Chief of Colorectal Surgery at NewYork-Presbyterian/Weill Cornell Medical Center. He established it and led it to become one of the top colorectal programs in the country. An early adopter of minimally invasive GI therapies almost 30 years ago, he led the first prospective randomized trial in the country, comparing the benefits of laparoscopic vs. conventional “open” surgery for colorectal cancer. He has a long history of working with industry leaders to create new methods and devices, has dozens of patents in device development, and has commercialized many of his ideas. He is also leading the surgeon-based International Collaboration on Colorectal Cancer (IC3), a group formed from over 10 countries to improve outcomes in colon and rectal cancer. His continued success in creating new, safe, and practical procedures has inspired surgeons and trainees for decades, and he has been invited to perform minimally invasive surgery on patients in more than 35 countries during his career.

CO-DIRECTOR

Dr. Bradley Pua is the Chief of Vascular and Interventional Radiology at NewYork-Presbyterian/Weill Cornell. In addition to his work with advanced imaging modalities for early detection of cancer, he focuses on using thermal ablative techniques to treat cancer and optimizing these techniques. As a result of his efforts, Dr. Pua has been invited to speak at several national engagements, publish manuscripts, and participate in numerous multicenter clinical trials. He has built strong collaborations with industry leaders, focusing on advanced imaging techniques as they pertain to minimally invasive procedures. Having initially trained in surgery, he participated in early research in minimally invasive techniques and the incorporation of robotics into surgery, before pursuing a career in interventional radiology. Dr. Pua is harnessing his expertise in both fields to partner with Dr. Milsom to achieve their combined goals.

CO-DIRECTOR

Dr. Art Sedrakyan, originally trained as a cardiovascular surgeon, has also earned a PhD in health policy and management. He now directs the Institute for Health Technologies and Interventions at NewYork-Presbyterian/Weill Cornell. He has initiated 15 major national and international coordinated research networks in collaboration with the FDA. He has experience as a senior advisor at the FDA Center for Devices and Radiological Health, and served as a Vice Chair of the Medicare Evidence Development & Coverage Advisory Committee advising on new technology coverage for the Centers for Medicare & Medicaid Services). He is the Vice Chair of IDEAL Collaboration, the leading international surgical research initiative with a focus on devices. He is serving as a specialist advisor for the Australian Therapeutic Goods Administration, expert for European Commission Horizon 2020 technology funding, and Japan Agency for Medical Research and Development. Since May 2019, he has served as a founding Co-Editor-in-Chief of BMJ Surgery, Interventions, & Health Technologies. Dr. Sedrakyan and his team have created our data integration system, HIVE, for clinical and research data synthesis, reporting, and advanced machine learning capabilities.

SENIOR ADVISOR

Emme Deland, MBA, is Senior Vice President of Strategy and Senior Advisor to the Dalio Center for Health Justice at NewYork-Presbyterian. Emme is the strategic advisor to the Center’s efforts to address longstanding health disparities due to race, socio-economic differences, limited access to care, and other complex factors that impact the wellbeing of our communities disproportionately. Prior, Emme was the Chief Strategy Officer responsible for developing clinical and corporate strategies for the enterprise, and for identifying, disseminating, and commercializing new innovation.